Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07118722

Mindfulness-based Cognitive Therapy vs the Health Enhancement Program for Chronic Pain and Depression; The Quiet Focus Study

Mindfulness-Based Cognitive Therapy Adapted for Older Adults At-Risk for the Chronic Pain-Depression Co-Morbidity; The Quiet Focus Pilot Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
50 Years – 120 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to pilot a randomized controlled trial comparing an adaptation of mindfulness-based cognitive therapy to the health enhancement program for chronic pain and depression. The main questions it aims to answer in a later fully powered randomized controlled trial are: * Is an adaptation of mindfulness-based cognitive therapy for older Black adults able to improve quality of life? * Will an adapted mindfulness based cognitive therapy reduce pain interference to a greater degree than a traditional health enhancement program?

Detailed description

Co-morbid chronic pain-depression is common among older Black adults and this co-morbidity worsens physical and emotional function. Access to evidence based non-pharmacological management is limited. Mindfulness based cognitive therapy (MBCT) is an evidence-based, non-pharmacological intervention that could address the chronic pain-depression co-morbidity among older Black adults, but it requires tailoring. The proposed study will establish the feasibility, acceptability and credibility of Quiet Focus, a cultural adaptation of MBCT aimed at the chronic pain-depression co-morbidity among older Black adults in the community.

Conditions

Interventions

TypeNameDescription
BEHAVIORALQuiet FocusMindfulness-based cognitive therapy adapted for older adults at-risk for chronic pain and depression
BEHAVIORALHealth Enhancement ProgramTime- and dose-matched control for Quiet Focus.

Timeline

Start date
2025-09-01
Primary completion
2026-07-01
Completion
2027-06-30
First posted
2025-08-12
Last updated
2025-10-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07118722. Inclusion in this directory is not an endorsement.